Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 3/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19773326 | 0.88 | SLC18A3 (0.37) | SLC18A3OPRM1OPRK1OPRD1 | |
| SCHEMBL12430499 | 0.80 | SLC18A3 (0.40) | SLC18A3OPRM1OPRK1OPRD1SIGMAR1 | |
| SCHEMBL12430313 | 0.80 | SLC18A3 (0.40) | SLC18A3OPRM1OPRK1OPRD1SIGMAR1 | |
| SCHEMBL12510576 | 0.79 | SLC18A3 (0.42) | SLC18A3OPRM1OPRK1OPRD1SIGMAR1 | |
| SCHEMBL20087337 | 0.78 | ADH1A (0.40) | SLC18A3OPRM1OPRK1OPRD1SIGMAR1 | |
| SCHEMBL21159067 | 0.75 | SLC18A3 (0.37) | SLC18A3OPRM1OPRK1OPRD1SIGMAR1 | |
| SCHEMBL20091610 | 0.74 | SIGMAR1 (0.32) | SIGMAR1 | |
| SCHEMBL24085914 | 0.73 | ADH1A (0.40) | SLC18A3OPRM1OPRK1OPRD1SIGMAR1 | |
| SCHEMBL26620832 | 0.73 | ADH1A (0.36) | SLC18A3OPRM1OPRK1OPRD1SIGMAR1 | |
| SCHEMBL7614419 | 0.71 | SLC18A3 (0.37) | SLC18A3OPRM1OPRK1OPRD1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10392449-B2 | Polymerization initiator, modified conjugated diene-based polymer, and methods for preparing them | LG CHEM, LTD. (KR) | 2019-08-27 | — | — | US | disclosed |
| US-20180112015-A1 | POLYMERIZATION INITIATOR, MODIFIED CONJUGATED DIENE-BASED POLYMER, AND METHODS FOR PREPARING THEM | LG CHEM, LTD. (KR) | 2018-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180112015-A1 | POLYMERIZATION INITIATOR, MODIFIED CONJUGATED DIENE-BASED POLYMER, AND METHODS FOR PREPARING THEM | RIF1, RAD51, TRRAP | SLC18A3 4867/4885OPRM1 2716/4885OPRK1 3657/4885 |
| US-10392449-B2 | Polymerization initiator, modified conjugated diene-based polymer, and methods for preparing them | RIF1, RAD51, TRRAP | SLC18A3 4867/4885OPRM1 2716/4885OPRK1 3657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.